EPG Wealth Management LLC Acquires 726 Shares of GE HealthCare Technologies Inc. $GEHC

EPG Wealth Management LLC boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 6.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 11,301 shares of the company’s stock after acquiring an additional 726 shares during the quarter. EPG Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $837,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in GEHC. Mutual Advisors LLC raised its position in GE HealthCare Technologies by 114.1% during the first quarter. Mutual Advisors LLC now owns 6,390 shares of the company’s stock valued at $516,000 after acquiring an additional 3,406 shares in the last quarter. Principal Financial Group Inc. raised its position in GE HealthCare Technologies by 2.4% during the first quarter. Principal Financial Group Inc. now owns 950,055 shares of the company’s stock valued at $76,679,000 after acquiring an additional 21,962 shares in the last quarter. Calamos Advisors LLC raised its position in GE HealthCare Technologies by 0.7% during the first quarter. Calamos Advisors LLC now owns 108,774 shares of the company’s stock valued at $8,779,000 after acquiring an additional 711 shares in the last quarter. Silver Oak Securities Incorporated bought a new position in GE HealthCare Technologies during the first quarter valued at approximately $243,000. Finally, OneDigital Investment Advisors LLC grew its holdings in GE HealthCare Technologies by 32.1% during the first quarter. OneDigital Investment Advisors LLC now owns 38,409 shares of the company’s stock valued at $3,100,000 after purchasing an additional 9,328 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 0.1%

GEHC opened at $74.95 on Monday. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $34.14 billion, a price-to-earnings ratio of 15.49, a P/E/G ratio of 2.82 and a beta of 1.13. The business has a 50 day moving average of $75.09 and a 200-day moving average of $73.14.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. During the same period in the prior year, the business earned $1.14 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

Wall Street Analyst Weigh In

GEHC has been the topic of several analyst reports. Wells Fargo & Company lowered their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a report on Thursday. Morgan Stanley increased their price target on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday, October 14th. Evercore ISI increased their price target on GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a report on Thursday. Finally, Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $86.10.

View Our Latest Stock Analysis on GEHC

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Recommended Stories

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.